Building up associations

IADSA has been involved in establishing more than 15 of its associations over the past decade. We work with companies and authorities to build national associations in countries where one does not exist.

Find out more

IADSA Scientific Publications

Search publications
  • Byron Johnson Chairman of IADSA

    Ensuring micronutrient adequacy for vulnerable groups around the world: the role of food supplements
    October 2011

    The importance of appropriate nutrition interventions to improve child health and development and good nutrition in utero has far-reaching implications for a nation’s economic development and the chance for people to prosper. Governments and health professionals already recognise the need for the use of food supplements in certain targeted population groups. However, significant proportions of the general population are failing to achieve adequate intakes of several micronutrients. A key objective of this IADSA publication is to promote better awareness of the potential role of food supplements in supporting a varied and balanced diet and to help improve the nutritional status of populations around the world.


  •  
  • Byron Johnson Chairman of IADSA

    The scientific Substantiation of Health Claims. A Global Analysis
    October 2010

    This report reviews ongoing recent developments and initiatives on the scientific substantiation of health claims around the world, such as the Codex Alimentarius Commission guidelines as well as developments in the European Union, the USA, China, Japan, the ASEAN countries and Latin America. It provides a snapshot of recent developments for methodologies, for the assessment of the totality of the available data and for the development of a scientific framework for weighing the strength, consistency and biological plausibility of the evidence.


  •  
  • Byron Johnson Chairman of IADSA

    The Updated Risk Assessment of Vitamin D
    October 2009

    The evolution of the human dataset relevant to vitamin D safety has been as rapid as that for efficacy. In the past decade, a large number of well-designed human clinical trials have been published involving relatively high doses of vitamin D in a range of populations and subgroups. These data, combined with a general scientific consensus of serum 25(OH)D levels as the marker for vitamin D status, have drastically informed our knowledge regarding the safety of vitamin D. Presented in this publication is an updated risk assessment of vitamin D based on the most recently published human clinical trials.


  •  
< previous 1 | Page 2 | 3 | 4 next >